These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34233589)

  • 1. Pneumococcal surface adhesion A protein (PsaA) interacts with human Annexin A2 on airway epithelial cells.
    Hu Y; Park N; Seo KS; Park JY; Somarathne RP; Olivier AK; Fitzkee NC; Thornton JA
    Virulence; 2021 Dec; 12(1):1841-1854. PubMed ID: 34233589
    [No Abstract]   [Full Text] [Related]  

  • 2. E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae.
    Anderton JM; Rajam G; Romero-Steiner S; Summer S; Kowalczyk AP; Carlone GM; Sampson JS; Ades EW
    Microb Pathog; 2007; 42(5-6):225-36. PubMed ID: 17412553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal surface adhesin A (PsaA): a review.
    Rajam G; Anderton JM; Carlone GM; Sampson JS; Ades EW
    Crit Rev Microbiol; 2008; 34(3-4):131-42. PubMed ID: 18728990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.
    Romero-Steiner S; Pilishvili T; Sampson JS; Johnson SE; Stinson A; Carlone GM; Ades EW
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):246-51. PubMed ID: 12626450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J; Cui YL; Jiang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
    Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial surface lipoproteins mediate epithelial microinvasion by
    Chan JM; Ramos-Sevillano E; Betts M; Wilson HU; Weight CM; Houhou-Ousalah A; Pollara G; Brown JS; Heyderman RS
    Infect Immun; 2024 May; 92(5):e0044723. PubMed ID: 38629841
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
    Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies.
    Romero-Steiner S; Caba J; Rajam G; Langley T; Floyd A; Johnson SE; Sampson JS; Carlone GM; Ades E
    Vaccine; 2006 Apr; 24(16):3224-31. PubMed ID: 16487631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and seroreactivity of pneumococcal surface adhesin A (PsaA).
    Tharpe JA; Russell H
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):227-9. PubMed ID: 8991641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal Infections and Invasive Potential of Nonencapsulated
    Bradshaw JL; Pipkins HR; Keller LE; Pendarvis JK; McDaniel LS
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.
    Wang S; Li Y; Shi H; Scarpellini G; Torres-Escobar A; Roland KL; Curtiss R
    Infect Immun; 2010 Jul; 78(7):3258-71. PubMed ID: 20479086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).
    Talkington DF; Brown BG; Tharpe JA; Koenig A; Russell H
    Microb Pathog; 1996 Jul; 21(1):17-22. PubMed ID: 8827703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media.
    Rapola S; Kilpi T; Lahdenkari M; Mäkelä PH; Käyhty H
    Pediatr Infect Dis J; 2001 May; 20(5):482-7. PubMed ID: 11368104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.
    De BK; Sampson JS; Ades EW; Huebner RC; Jue DL; Johnson SE; Espina M; Stinson AR; Briles DE; Carlone GM
    Vaccine; 2000 Mar; 18(17):1811-21. PubMed ID: 10699329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the psaA gene, coding for pneumococcal surface adhesin A, in viridans group streptococci other than Streptococcus pneumoniae.
    Jado I; Fenoll A; Casal J; Pérez A
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):895-8. PubMed ID: 11527799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.